Article

2 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 74, n° 6
pages 1251-1252 (juin 2016)
Doi : 10.1016/j.jaad.2015.09.065
Research Letters

Topical minocycline foam for moderate to severe acne vulgaris: Phase 2 randomized double-blind, vehicle-controlled study results
 

Avner Shemer, MD a, Joseph Shiri, MD b, Jacob Mashiah, MD, MHA c, Renata Farhi, MD d, Aditya K. Gupta, MD, PhD, FRCP(C) e,
a The Chaim Sheba Medical Center, Affiliated with Tel-Aviv University, Sackler School of Medicine, Tel Aviv, Israel 
b Clalit Health Services Clinic, Tel Aviv, Israel 
c Department of Dermatology, Pediatric Dermatology Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 
d Dermatology Department, Hospital Nossa Senhora da Saúde (Gamboa), Rio de Janeiro, Brazil 
e Department of Medicine, University of Toronto, and Mediprobe Research Inc, London, Ontario, Canada 

Correspondence to: Aditya K. Gupta, MD, PhD, FRCP(C), 645 Windermere Rd, London, Ontario, Canada N5X 2P1

 Funding sources: Foamix Pharmaceuticals Ltd.
 Disclosures: Dr Shemer is a consultant for Foamix Ltd. Drs Shiri, Mashiah, Farhi, and Gupta have no conflicts of interest to declare.


Top of the page

© 2015  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline
@@#110903@@